Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 1
2015 2
2017 1
2018 1
2020 2
2021 1
2022 1
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.
Shih DJH, Nayyar N, Bihun I, Dagogo-Jack I, Gill CM, Aquilanti E, Bertalan M, Kaplan A, D'Andrea MR, Chukwueke U, Ippen FM, Alvarez-Breckenridge C, Camarda ND, Lastrapes M, McCabe D, Kuter B, Kaufman B, Strickland MR, Martinez-Gutierrez JC, Nagabhushan D, De Sauvage M, White MD, Castro BA, Hoang K, Kaneb A, Batchelor ED, Paek SH, Park SH, Martinez-Lage M, Berghoff AS, Merrill P, Gerstner ER, Batchelor TT, Frosch MP, Frazier RP, Borger DR, Iafrate AJ, Johnson BE, Santagata S, Preusser M, Cahill DP, Carter SL, Brastianos PK. Shih DJH, et al. Among authors: aquilanti e. Nat Genet. 2020 Apr;52(4):371-377. doi: 10.1038/s41588-020-0592-7. Epub 2020 Mar 23. Nat Genet. 2020. PMID: 32203465 Free PMC article.
Telomerase as a therapeutic target in glioblastoma.
Aquilanti E, Kageler L, Wen PY, Meyerson M. Aquilanti E, et al. Neuro Oncol. 2021 Dec 1;23(12):2004-2013. doi: 10.1093/neuonc/noab203. Neuro Oncol. 2021. PMID: 34473298 Free PMC article. Review.
Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants.
Hayes TK, Aquilanti E, Persky NS, Yang X, Kim EE, Brenan L, Goodale AB, Alan D, Sharpe T, Shue RE, Westlake L, Golomb L, Silverman BR, Morris MD, Fisher TR, Beyene E, Li YY, Cherniack AD, Piccioni F, Hicks JK, Chi AS, Cahill DP, Dietrich J, Batchelor TT, Root DE, Johannessen CM, Meyerson M. Hayes TK, et al. Among authors: aquilanti e. Nat Commun. 2024 Mar 28;15(1):2742. doi: 10.1038/s41467-024-45594-4. Nat Commun. 2024. PMID: 38548752 Free PMC article.
Updates in prognostic markers for gliomas.
Aquilanti E, Miller J, Santagata S, Cahill DP, Brastianos PK. Aquilanti E, et al. Neuro Oncol. 2018 Nov 9;20(suppl_7):vii17-vii26. doi: 10.1093/neuonc/noy158. Neuro Oncol. 2018. PMID: 30412261 Free PMC article.
Passenger deletions generate therapeutic vulnerabilities in cancer.
Muller FL, Colla S, Aquilanti E, Manzo VE, Genovese G, Lee J, Eisenson D, Narurkar R, Deng P, Nezi L, Lee MA, Hu B, Hu J, Sahin E, Ong D, Fletcher-Sananikone E, Ho D, Kwong L, Brennan C, Wang YA, Chin L, DePinho RA. Muller FL, et al. Among authors: aquilanti e. Nature. 2012 Aug 16;488(7411):337-42. doi: 10.1038/nature11331. Nature. 2012. PMID: 22895339 Free PMC article.
Collateral Lethality: A new therapeutic strategy in oncology.
Muller FL, Aquilanti EA, DePinho RA. Muller FL, et al. Among authors: aquilanti ea. Trends Cancer. 2015 Nov 1;1(3):161-173. doi: 10.1016/j.trecan.2015.10.002. Trends Cancer. 2015. PMID: 26870836 Free PMC article.
15 results